U.S. Pharmaceuticals & Biotech Blue chip stocks

Biogen

Market Cap: US$29.8b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Elanco Animal Health

Market Cap: US$12.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Charles River Laboratories International

Market Cap: US$11.1b

Charles River Laboratories International, Inc.

Waters

Market Cap: US$36.8b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Natera

Market Cap: US$38.7b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Axsome Therapeutics

Market Cap: US$10.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Insmed

Market Cap: US$21.3b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

ICON

Market Cap: US$12.2b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

BioMarin Pharmaceutical

Market Cap: US$11.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$29.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.1b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Viatris

Market Cap: US$20.5b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Jazz Pharmaceuticals

Market Cap: US$15.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BeOne Medicines

Market Cap: US$34.9b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Eli Lilly

Market Cap: US$1.0t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Royalty Pharma

Market Cap: US$33.1b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Neurocrine Biosciences

Market Cap: US$16.9b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Merck

Market Cap: US$315.6b

Operates as a healthcare company worldwide.

Gilead Sciences

Market Cap: US$162.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.